A non-inferiority trial of cytisine versus varenicline for smoking cessation. [ 2016 - 2019 ]

Research Grant

[Cite as]

Researchers: Prof Michael Farrell (Principal investigator) ,  A/Pr Christine Paul A/Pr Coral Gartner A/Pr Dennis Petrie A/Pr Stuart Ferguson
View all 7 related researchers

Brief description Long-term quit rates via existing behavioural and pharmacological approaches to smoking cessation remain low and there is a need for further evidence-based treatments to complement standard treatment. We will conduct a large-scale trial to demonstrate the cost-effectiveness of cytisine compared to existing varenicline treatment. The findings will have direct health care system implications and cytisine, if effective, has the potential to save millions of lives globally.

Funding Amount $AUD 1,942,717.35

Funding Scheme Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]